@article {7869,
	title = {The International Prognostic Scoring System for Waldenstr{\"o}m{\textquoteright}s macroglobulinemia is applicable in patients treated with rituximab-based regimens},
	journal = {Haematologica},
	volume = {93},
	year = {2008},
	note = {Cited By :29Export Date: 21 February 2017},
	month = {2008},
	pages = {1420 - 1422},
	keywords = {Cause-specific survival, High risk, Prognosis, rituximab},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849133905\&doi=10.3324\%2fhaematol.12846\&partnerID=40\&md5=bbef7c7aaaa5b50a0e2a0ef70a261491},
	author = {Dimopoulos, M.A. and Kastritis, E. and Delimpassi, S. and Zomas, A. and Kyrtsonis, M.C. and Zervas, K.}
}
